


格隆汇7月3日丨昂利康(002940.SZ)公布,近日,浙江昂利康制药股份有限公司收到国家药品监督管理局签发的苯磺酸氨氯地平片(5mg、10mg)《药品注册证书》。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”